ScreenerHero

ALNEVNeovacs S.A.

EPA · FR · Healthcare · Biotechnology · neovacs.com
0.6220EUR-7.80%Mkt Cap: 30 $P/E: —

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune disea…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap30 $
Enterprise Value460.70K $
Revenue (TTM)216.59K $
Gross Profit46.11K $
Net Income (TTM)-35.78M $
Revenue/Share0.4543 USD
Last Price0.6220 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees16
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR00140077X1
Valuation
P/E (Trailing)—
P/E (Forward)6.12
PEG—
EV/EBITDA-0.08
EV/Revenue2.13
P/S0.00
P/B0.02
EPS (TTM)-221.36
EPS (Forward)0.10
52W Range
0.00020% of range8099.00
52W High8099.00 EUR
52W Low0.0002 EUR
Profitability
Gross Margin11.58%
Oper. Margin-1683.64%
EBITDA Margin0.00%
Profit Margin-8984.51%
ROE-182.23%
ROA-149.13%
Growth
Revenue Growth-59.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.91M $
CapEx (TTM)86.64K $
FCF Margin-1918.64%
FCF Yield-13654360.71%
Net Debt143.64K $
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity0.01
Current Ratio0.67
Quick Ratio0.65
Book Value/Sh39.63 EUR
Cash/Share0.0810 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10000
Split DateJun 23, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.47
Float—
Insiders—
Institutions—
Technical
SMA 501.144 (-45.6%)
SMA 20033.97 (-98.2%)
Beta-1228.17
S&P 52W Chg19.18%
Avg Vol (30d)27.73K
Avg Vol (10d)65.06K
Technical Indicators
RSI (14)39.4
MACD-0.1275
MACD Signal-0.1375
MACD Hist.+0.0100
BB Upper1.091 EUR
BB Middle0.8025 EUR
BB Lower0.5140 EUR
BB Width71.90%
ATR (14)0.2116 EUR
Vol Ratio (20d)0.89x